BioCopy raises €8M to cut cancer drug development from years to months. The funding will help establish an automated ultra-high-throughput lab for faster biotherapeutics development.
Amount Raised
€8 Million
Round Type
Funding Round
BaselBiotechnologyDescription
The German-Swiss biotech BioCopy has secured €8 million in funding. This funding aims to reduce R&D time for cancer drugs from three years to 12 months and significantly lower development costs. BioCopy's innovative approach will allow testing of 25,000 drug candidates in parallel using AI-assisted technology. By optimizing drug production processes, the company aims to address the increasing demand for cancer treatments.
Quick answer
BioCopy raised €8 Million in a Funding Round round, dated March 20, 2025. BioCopy is based in Basel, Basel City, Switzerland.
- How much did BioCopy raise?
- BioCopy raised €8 Million in a Funding Round round on March 20, 2025.
- What does BioCopy do?
- BioCopy is a German-Swiss biotech company focused on the discovery and development of biotherapeutic drugs.
- Where is BioCopy based and how big is it?
- BioCopy is based in Basel, Basel City, Switzerland. Fundz records about 39 employees.
- Who are the decision-makers at BioCopy?
- Fundz holds 1 contact at BioCopy. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as BioCopy that raised within 45 days of this round, from Fundz verified event records.
- Solena Materials raised $6.7M (Seed) on May 3, 2025.
- NewLimit raised $130M on May 2, 2025.
- Hoofprint Biome raised $15M (Series A) on May 2, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
- AMPLY Discovery raised $1.8M (Seed) on May 1, 2025.
- Stately Bio raised $12M (Seed) on May 1, 2025.
Who to call at BioCopy, and when
A new round usually means BioCopy is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioCopy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioCopy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioCopy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioCopy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioCopy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.